eGFR group 1 eGFR ≥ 75.0 ml per minute per 1.73 m2 (n = 1772) | eGFR group 2 60.0 ≤ ≤74.9 ml per minute per 1.73 m2 (n = 2071) | eGFR group 3 45 ≤ ≤59.9 ml per minute per 1.73 m2 (n = 1726) | eGFR group 4 eGFR <45 ml per minute per 1.73 m2 (n = 1107) | P Value* | |
---|---|---|---|---|---|
Age (SD) | 59.7 | 66.6 | 71.1 | 75.0 | <0.0001 |
Gender,% | |||||
Women | 16.9 | 28.4 | 42.5 | 49.9 | <0.0001 |
Men | 83.1 | 71.6 | 57.5 | 50.1 | |
Body mass index (SD) | 25,8 | 25.9 | 25.6 | 25.2 | <0.0001 |
Creatinine (mean), μmol/l | 80.1 | 95.6 | 112.1 | 174.5 | <0.0001 |
Hypertension,% | 15.9 | 20.4 | 25.8 | 32.8 | <0.0001 |
Diabetes,% | 6.7 | 9.8 | 12.1 | 17.2 | <0.0001 |
Angina pectoris% | 27.5 | 36.0 | 42.1 | 45.2 | <0.0001 |
Previous MI,% | 17.0 | 22.6 | 26.0 | 30.8 | <0.0001 |
Heart failure,% | 34.2 | 48.8 | 64.1 | 77.3 | <0.0001 |
Smoking,% | |||||
Previously | 16.9 | 22.2 | 24.9 | 25.1 | <0.0001 |
Currently | 65.8 | 52.9 | 44.5 | 36.2 | |
Thrombolysis,% | 49.7 | 45.3 | 37.4 | 23.7 | <0.0001 |
Previous stroke,% | 4.6 | 7.0 | 9.4 | 14.2 | <0.0001 |
Diuretic treatment,%*** | 25.2 | 40.2 | 53.7 | 70.0 | <0.0001 |
Digoxin at discharge,%*** | 7.2 | 13.9 | 21.0 | 31.3 | <0.0001 |
ACE inhibitor at discharge,%*** | 4.2 | 5.8 | 9.8 | 15.3 | <0.0001 |
NYHA,% | |||||
Class I | 68.3 | 62.2 | 51.6 | 38.9 | <0.0001 |
Class II | 25.6 | 27.6 | 31.4 | 33.4 | |
Class III | 2.2 | 3.8 | 5.4 | 6.6 | |
Class IV | 2.6 | 4.3 | 7.8 | 15.5 | |
Killip**,% | |||||
Class I | 88.6 | 82.8 | 74.2 | 62.8 | <0.0001 |
Class II | 9.1 | 13.5 | 18.6 | 21.9 | |
Class III | 0.5 | 1.3 | 2.6 | 5.4 | |
Class IV | 1.9 | 2.3 | 4.7 | 9.9 | |
Wall motion index,% | |||||
>1,6 | 42.5 | 33.4 | 28.9 | 21.8 | <0.0001 |
1,3-1,6 | 24.7 | 24.5 | 22.4 | 21.8 | |
0,8-1,2 | 26.2 | 33.1 | 35.4 | 34.2 | |
<0,8 | 2.0 | 4.0 | 6.3 | 9.8 | |
Not classified | 4.5 | 5.0 | 7.0 | 12.6 | |
Ventricular fibrillation.%**** | 5.4 | 6.5 | 9.3 | 8.0 | <0.0001 |
Ventricular tachycardia,%**** | 12.2 | 12.8 | 13.1 | 12.6 | 0.8744 |
Atrial fibrillation,%**** | 12.3 | 18.2 | 25.6 | 32.4 | <0.0001 |